BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6892191)

  • 1. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of cis-diamminedichloroplatinum (II) in genitourinary cancer].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):433-42. PubMed ID: 6764107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of CIS-diamminedichloroplatinum (II) by collaborative study].
    Kato T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):694-701. PubMed ID: 6892198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase I study of a new antineoplastic agent, cis-diamminedichloroplatinum (II)].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):38-45. PubMed ID: 6892190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of UFT for malignant tumors of urinary organs].
    Shida K; Yamanaka H; Ito Y; Shimazaki J; Isaka S; Yokokawa M; Fukui I; Kawai H; Akimoto M; Yoshida K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1307-14. PubMed ID: 6428325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
    Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
    Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.
    Yagoda A
    Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
    Merrin CE
    Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
    [No Abstract]   [Full Text] [Related]  

  • 12. cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies.
    Sarna G; Skinner DG; Smith RB; Zighelboim J; Goodnight JE; Feig S
    Cancer Treat Rep; 1980; 64(10-11):1077-82. PubMed ID: 7193086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of urologic malignancies.
    Scher HI; Sternberg CN
    Semin Urol; 1985 Nov; 3(4):239-80. PubMed ID: 3916569
    [No Abstract]   [Full Text] [Related]  

  • 14. [The chemotherapy of urologic neoplasms].
    Cavalli F
    Helv Chir Acta; 1978 Jul; 45(3):223-32. PubMed ID: 359509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
    Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
    Salem P; Hall SW; Benjamin RS; Murphy WK; Wharton JT; Bodey GP
    Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
    Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
    Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
    Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
    Machida T; Koiso K; Takaku F; Ogawa M
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.